Percutaneous pulmonary valve implantation (PPVI) in non-obstructive right ventricular outflow tract: limitations and mid-term outcomes | Zendy

Anoosh Esmaeili | Zendy; Markus Khalil | Zendy; K. Behnke-Hall | Zendy; M.B. González | Zendy; Gunter Kerst | Zendy; Stephan Fichtlscherer | Zendy; Hakan Akintuerk | Zendy; Dietmar Schranz | Zendy

Open Access

Percutaneous pulmonary valve implantation (PPVI) in non-obstructive right ventricular outflow tract: limitations and mid-term outcomes

Author(s) -

Anoosh Esmaeili,

Markus Khalil,

K. Behnke-Hall,

M.B. González,

Gunter Kerst,

Stephan Fichtlscherer,

Hakan Akintuerk,

Dietmar Schranz

Publication year - 2019

Publication title -

translational pediatrics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.702

H-Index - 13

eISSN - 2224-4344

pISSN - 2224-4336

DOI - 10.21037/tp.2019.04.02

Subject(s) - medicine , ventricular outflow tract , cardiology , pulmonary valve , balloon , percutaneous , interventional cardiology , stent , surgery

Percutaneous pulmonary valve implantation (PPVI) has been established as a safe and effective alternative to surgery treating patients with a failing pulmonary valve conduit. Nevertheless, the majority of patients in need of a valve have a native, non-obstructive right ventricular outflow tract (RVOT). The current approved stent-valves have a balloon-expandable design. Pre-stenting of the RVOT to create a landing zone and also protect the valve stability is usually mandatory; large, non-obstructive RVOTs need pre-stenting to reduce the RVOT-diameter for a balloon-expandable valve implantation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research